By using this site, you are consenting to our use of cookies. To find out more visit our privacy policy.
Includes articles, courses, and CPGs. Unlimited access for APTA members.
Aug 1, 2022/CPG
This update of a 2016 guideline provides assistance to physical therapists in the decision-making process when treating patients at risk for venous thromboembolism (VTE) or diagnosed with a lower extremity deep vein thrombosis (LE DVT).
Jan 1, 2020/CPG
This document will guide physical therapist practice in the examination and treatment of patients with a known diagnosis of heart failure.
Jul 1, 2020/CPG
The Academy of Oncologic Physical Therapy of APTA published its first major treatment-related clinical practice guideline — a resource on treatment of lymphedema related to breast cancer targeted specifically at the PT's role.
Nov 4, 2024/Test & Measure
Various patient-reported and clinician-administered tools can screen individuals for auditory impairment.
Apr 22, 2022/Test & Measure
URICA measures a using a patient's readiness to change self-reported questionnaire that categorizes the patient into one of the 4 following stages: precontemplation, contemplation, action, or maintenance.
Dec 28, 2022/Test & Measure
This brief self-report measure was developed to help identify people who may have generalized anxiety disorder.
Nov 29, 2023/Test & Measure
A screening tool that measures the risk of venous thrombus embolism (VTE).
Sep 1, 2015/Column
As provisions of the new law take effect, PTs had best adopt quality measures and learn more about innovative care-delivery models being created in their communities.
Jul 1, 2017/Column
CMS is reviewing some therapy claims that exceed the $3,700 Medicare Part B threshold. Here's what to know, and what to do, if you are contacted
Nov 1, 2016/Column
CMS launches a pre-claim review demonstration in 5 states. Here are the key points.